<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.peertechzpublications.org/assets/xsl/oaitohtml.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
										<responseDate>2026-04-10T23:56:19Z</responseDate>
										<request verb="GetRecord" metadataPrefix="oai_dc" identifier="oai:www.peertechzpublications.org:10.17352/2455-3786.000119">https://www.peertechzpublications.org/oai-pmh</request><GetRecord><record>
								<header>
									<identifier>oai:www.peertechzpublications.org:10.17352/2455-3786.000119</identifier>
									<datestamp>2017-01-27</datestamp>
									<setSpec>PTZ.JHCSR:VOL4</setSpec>
								</header>
								<metadata>
									<oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
										<dc:title>
										Hepatitis C – Human Immunodeficiency Virus Coinfection and the Risk of Cerebro-Cardiovascular Diseases: Is There Enough Evidence to Draw Conclusion and Establish Guideline?
										</dc:title><dc:creator>Muhammad Yusra Firdaus</dc:creator><dc:creator>Ikhwanuliman Putera</dc:creator><dc:description>&lt;p&gt;During the last decade, the link between Human Immunodefi ciency Virus (HIV) infection and cardiovascular disease has received much attention. Recent meta-anaylsis by Islam et al. [1], concluded that HIV infection increases the risk of cardiovascular diseases (CVD). They found the relative risk (RR)&lt;/p&gt;&lt;p&gt;of CVD among people living with HIV (PLHIV) was 1.61 (95% CI 1.43-1.81). Despite the introduction of&amp;nbsp; antiretroviral therapy (ART) which increase survival of PLHIV, ART itself increase the risk of CVD (RR 2,00 95% CI 1,70-2,37) [1]. Management of HIV has shifted from treating the disease to managing complication and chronic condition such as atherosclerosis [2].&lt;/p&gt;</dc:description>
										<dc:publisher>Journal of HIV for Clinical and Scientific Research - Peertechz Publications</dc:publisher>
										<dc:date>2017-01-27</dc:date>
										<dc:type>Editorial</dc:type>
										<dc:identifier>https://doi.org/10.17352/2455-3786.000119</dc:identifier>
										<dc:language>en</dc:language>
										<dc:rights>Copyright © Muhammad Yusra Firdaus et al.</dc:rights>
									</oai_dc:dc>
								</metadata>
							</record></GetRecord>
						</OAI-PMH>
